Blood Res.  2017 Jun;52(2):143-145. 10.5045/br.2017.52.2.143.

The imbalance of procoagulant and anticoagulant factors in patients with chronic liver diseases in North India

• Saxena P
• Bihari C
• Mirza R
• Bhadoria A
• Sarin SK

• KMID: 2413336
• DOI: http://doi.org/10.5045/br.2017.52.2.143

Abstract

No abstract available.

MeSH Terms

Humans
India*
Liver Diseases*
Liver*

Reference

1. Lisman T, Caldwell SH, Burroughs AK, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010; 53:362–371.

2. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004; 91:267–275.

3. Noe DA, Murphy PA, Bell WR, Siegel JN. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol. 1989; 257:R49–R56.

4. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009; 3:269–282.

5. Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol. 2001; 21:731–738.

6. Dahlbäck B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol. 2004; 79:109–116.

7. Tripodi A, Primignani M, Lemma L, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology. 2010; 52:249–255.

8. Agarwal B, Wright G, Gatt A, et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012; 57:780–786.